As the world scrambles to repurpose approved treatments and develop new ones to tackle the deadly coronavirus, Indian firms are moving quietly alongside in sync, hoping to accelerate development activities or scale up plans for such potential therapies. Domestic firms are also keeping close watch on developments around an encouraging French study on the potential of hydroxychloroquine and azithromycin as a treatment for COVID-19.
[Sidebar#SC141858]






